James Brian Windsor - Mar 5, 2024 Form 4 Insider Report for AILERON THERAPEUTICS INC (ALRN)

Signature
/s/ James Brian Windsor
Stock symbol
ALRN
Transactions as of
Mar 5, 2024
Transactions value $
$0
Form type
4
Date filed
3/6/2024, 05:06 PM
Previous filing
Dec 18, 2023
Next filing
Dec 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALRN Common Stock Options Exercise +2K +39.05% 7.12K Mar 5, 2024 Direct F1
holding ALRN Common Stock 225 Mar 5, 2024 By son F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRN Series X Non-Voting Convertible Preferred Options Exercise -2 -100% 0 Mar 5, 2024 Common Stock 2K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share ("Series X Preferred Stock") automatically converted into shares of common stock of the Issuer, par value $0.001 per share ("Common Stock"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration.
F2 The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.